MICHAEL LARKNER: Open Payments
NPI 1780360693 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 25 payments from 9 companies in 2025. Trend: 2023 $93 · 2024 $292 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $234 |
| GENZYME CORPORATION | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Optinose US, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Acera Surgical, Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Olympus America Inc. | 1 | $16 |
Products named: DUPIXENT, LIBTAYO, TEZSPIRE, Xhance, NUCALA, KEYTRUDA, Restrata Wound Matrix, Ryaltris.
Industry payments across TN — which companies pay providers there.
